Other
For Intravenous or Intramuscular Use
sagent®
Rx only
To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftazidime for injection and other antibacterial drugs, ceftazidime for injection should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.
For direct intermittent IV administration, constitute ceftazidime for injection as directed in Table 5 with Sterile Water for Injection. Slowly inject directly into the vein over a period of 3 to 5 minutes or give through the tubing of an administration set while the patient is also receiving one of the compatible IV fluids (see COMPATIBILITY AND STABILITY).
For IV infusion, constitute the 1 gram, or 2 gram vial and add an appropriate quantity of the resulting solution to an IV container with one of the compatible IV fluids listed under the COMPATIBILITY AND STABILITY section.
Intermittent IV infusion with a Y-type administration set can be accomplished with compatible solutions. However, during infusion of a solution containing ceftazidime, it is desirable to discontinue the other solution.
* To obtain a dose of 1 g, withdraw 10 mL from the vial following reconstitution. | |||
** To obtain a dose of 2 g, withdraw 11.5 mL from the vial following reconstitution. | |||
Size | Amount of Diluent to be Added (mL) | Approximate Available Volume (mL) | Approximate Ceftazidime Concentration (mg/mL) |
| Intramuscular | |||
| 1 gram vial | 3 | 3.6 | 280 |
| Intravenous | |||
| 1 gram vial | 10 | 10.8* | 100 |
| 2 gram vial | 10 | 11.5** | 170 |
Discard unused portion.
All vials of ceftazidime for injection as supplied are under reduced pressure. When ceftazidime for injection is dissolved, carbon dioxide is released and a positive pressure develops. For ease of use please follow the recommended techniques of constitution described on the detachable Instructions for Constitution section of this insert.
Solutions of ceftazidime for injection, like those of most beta-lactam antibacterial drugs, should not be added to solutions of aminoglycoside antibacterial drugs because of potential interaction.
However, if concurrent therapy with ceftazidime for injection and an aminoglycoside is indicated, each of these antibacterial drugs can be administered separately to the same patient.